Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation.
Bijkerk R, Aleksinskaya MA, Duijs JMGJ, Veth J, Husen B, Reiche D, Prehn C, Adamski J, Rabelink TJ, De Mey JGR, van Zonneveld AJ.
Bijkerk R, et al. Among authors: husen b.
Clin Sci (Lond). 2019 Jan 22;133(2):239-252. doi: 10.1042/CS20180882. Print 2019 Jan 31.
Clin Sci (Lond). 2019.
PMID: 30617188